Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 735

    1.

    Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial.

    Azadbakht L, Atabak S, Esmaillzadeh A.

    Diabetes Care. 2008 Apr;31(4):648-54. Epub 2008 Jan 9.PMID: 18184902 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy.

    Azadbakht L, Shakerhosseini R, Atabak S, Jamshidian M, Mehrabi Y, Esmaill-Zadeh A.

    Eur J Clin Nutr. 2003 Oct;57(10):1292-4.PMID: 14506491 [PubMed - indexed for MEDLINE]Related articles

    3.

    Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects.

    Hermansen K, Søndergaard M, Høie L, Carstensen M, Brock B.

    Diabetes Care. 2001 Feb;24(2):228-33.PMID: 11213870 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy.

    Teixeira SR, Tappenden KA, Carson L, Jones R, Prabhudesai M, Marshall WP, Erdman JW Jr.

    J Nutr. 2004 Aug;134(8):1874-80.PMID: 15284369 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Dietary flaxseed meal reduces proteinuria and ameliorates nephropathy in an animal model of type II diabetes mellitus.

    Velasquez MT, Bhathena SJ, Ranich T, Schwartz AM, Kardon DE, Ali AA, Haudenschild CC, Hansen CT.

    Kidney Int. 2003 Dec;64(6):2100-7.PMID: 14633132 [PubMed - indexed for MEDLINE]Related articles

    6.

    Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy.

    Friedman AN, Hunsicker LG, Selhub J, Bostom AG.

    Atherosclerosis. 2004 Jan;172(1):121-5.PMID: 14709365 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects.

    Matthan NR, Jalbert SM, Ausman LM, Kuvin JT, Karas RH, Lichtenstein AH.

    Am J Clin Nutr. 2007 Apr;85(4):960-6. Erratum in: Am J Clin Nutr. 2007 Aug;86(2):525. PMID: 17413093 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).

    Freedman BI, Wuerth JP, Cartwright K, Bain RP, Dippe S, Hershon K, Mooradian AD, Spinowitz BS.

    Control Clin Trials. 1999 Oct;20(5):493-510.PMID: 10503809 [PubMed - indexed for MEDLINE]Related articles

    9.

    Soy-protein consumption and kidney-related biomarkers among type 2 diabetics: a crossover, randomized clinical trial.

    Azadbakht L, Esmaillzadeh A.

    J Ren Nutr. 2009 Nov;19(6):479-86. Epub 2009 Sep 15.PMID: 19758824 [PubMed - in process]Related articles

    10.

    Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.

    Tarnow L, Rossing P, Nielsen FS, Hansen BV, Dyerberg J, Parving HH.

    Diabetes Care. 1996 Dec;19(12):1382-7.PMID: 8941468 [PubMed - indexed for MEDLINE]Related articles

    11.

    Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes.

    Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA, Atkin SL.

    Diabetes Care. 2002 Oct;25(10):1709-14.PMID: 12351466 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.

    Nielsen FS, Voldsgaard AI, Gall MA, Rossing P, Hommel E, Andersen P, Dyerberg J, Parving HH.

    Diabetologia. 1993 May;36(5):438-44.PMID: 8314449 [PubMed - indexed for MEDLINE]Related articles

    13.

    Long-term effects of protein-restricted diet on albuminuria and renal function in IDDM patients without clinical nephropathy and hypertension.

    Dullaart RP, Beusekamp BJ, Meijer S, van Doormaal JJ, Sluiter WJ.

    Diabetes Care. 1993 Feb;16(2):483-92.PMID: 8432221 [PubMed - indexed for MEDLINE]Related articles

    14.

    C-reactive protein and incident cardiovascular events among men with diabetes.

    Schulze MB, Rimm EB, Li T, Rifai N, Stampfer MJ, Hu FB.

    Diabetes Care. 2004 Apr;27(4):889-94.PMID: 15047644 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.

    Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H.

    Diabetes Care. 2005 Nov;28(11):2728-32.PMID: 16249547 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of a soy protein diet on serum lipids of renal transplant patients.

    Cupisti A, D'Alessandro C, Ghiadoni L, Morelli E, Panichi V, Barsotti G.

    J Ren Nutr. 2004 Jan;14(1):31-5.PMID: 14740328 [PubMed - indexed for MEDLINE]Related articles

    17.

    Relation of serum total sialic acid concentrations with diabetic complications and cardiovascular risk factors in Kuwaiti Type 2 diabetic patients.

    Abdella N, Akanji AO, Mojiminiyi OA, Al Assoussi A, Moussa M.

    Diabetes Res Clin Pract. 2000 Sep;50(1):65-72.PMID: 10936670 [PubMed - indexed for MEDLINE]Related articles

    18.

    Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.

    Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH.

    Diabetes Care. 2004 Mar;27(3):765-9.PMID: 14988299 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein.

    Li Z, Hong K, Saltsman P, DeShields S, Bellman M, Thames G, Liu Y, Wang HJ, Elashoff R, Heber D.

    Eur J Clin Nutr. 2005 Mar;59(3):411-8.PMID: 15674301 [PubMed - indexed for MEDLINE]Related articles

    20.

    Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.

    Mormile A, Veglio M, Gruden G, Girotto M, Rossetto P, D'Este P, Cavallo-Perin P.

    Acta Diabetol. 1996 Sep;33(3):241-5.PMID: 8904933 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data